Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharide

Journal of Bacteriology

Volumn 193, Issue 14, 2011, Pages 3506-3511

  Tamborrini, Marco ^a,b   Bauer, Mark ^a,b,h   Bolz, Miriam ^a,b   Maho, Angaya ^c   Oberli, Matthias A ^d,i   Werz, Daniel B ^e   Schelling, Esther ^a,b   Zinsstag, Jakob ^a,b   Seeberger, Peter H ^d,f   Frey, Joachim ^g   Pluschke, Gerd ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Laboratoire de Recherches Vétérinaire et Zootechnique   (Chad)

^d MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f FREIE UNIVERSITÄT BERLIN   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h Institute of Biochemistry and Molecular Medicine   (Switzerland)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTHRAX VACCINE; ANTHROSE; EPITOPE; GLYCAN; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; PENTASACCHARIDE; TETRASACCHARIDE; UNCLASSIFIED DRUG;

AFRICA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIGENICITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL ENDOSPORE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CAMEROON; CARCASS; CATTLE; CHAD; CONTROLLED STUDY; CROSS REACTION; ENDEMIC DISEASE; ENZYME SYNTHESIS; GENE EXPRESSION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC PARAMETERS; IMMUNOBLOTTING; IMMUNOLOGICAL PARAMETERS; LIVESTOCK; MALI; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; STOP CODON; VACCINE PRODUCTION;

AFRICA; AMINO SUGARS; ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; CATTLE; CATTLE DISEASES; DEOXYGLUCOSE; GENE EXPRESSION REGULATION, BACTERIAL; OLIGOSACCHARIDES; SPORES, BACTERIAL;

BACILLUS ANTHRACIS; BOS;

EID: 79960397262     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00078-11     Document Type: Article

References (33)

1. Adamo, R., R. Saksena, and P. Kováč. 2005. Synthesis of the ß anomer of the spacer-equipped tetrasaccharide side chain of the major glycoprotein of the Bacillus anthracis xosporium. Carbohydr. Res. 340:2579-2582.
2. Cohen, S., et al. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 8:4549-4558.
3. Crich, D., and O. Vinogradova. 2007. Synthesis of the antigenic tetrasaccharide side chain from the major glycoprotein of Bacillus anthracis exosporium. J. Org. Chem. 72:6513-520.
4. Daubenspeck, J. M., et al. 2004. Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J. Biol. Chem. 0:30945-30953.
5. Dhénin, S. G., et al. 2008. Synthesis of an anthrose derivative and production of polyclonal antibodies for the detection of anthrax spores. Carbohydr. Res. 343:2101-2110.
6. Dong, S., S. A. McPherson, L. Tan, O. N. Chesnokova, C. L. Turnbough, Jr., and D. G. Pritchard. 2008. Anthrose biosynthetic operon of Bacillus anthracis. J. Bacteriol. 90:2350-2359.
7. Dong, S., et al. 2010. Characterization of the enzymes encoded by the anthrose biosynthetic operon of Bacillus anthracis. J. Bacteriol. 192:5053- 5062.
8. Guo, H., and G. A. O'Doherty. 2007. De novo asymmetric synthesis of the anthrax tetrasaccharide by a palladium-catalyzed glycosylation reaction. Angew Chem. Int. 46:5206-208.
9. Keim, P., et al. 2000. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J. Bacteriol. 182:2928- 2936.
10. Kubler-Kielb, J., et al. 2008. Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component. Proc. Natl. Acad. Sci. U. S. A. 25:8709-712.
11. Kuehn, A., et al. 2009. Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores. Clin. Vaccine Immunol. 12:1728-1737.
12. Maho, A., et al. 2006. Antibiotic susceptibility and molecular diversity of Bacillus anthracis strains in Chad: detection of a new phylogenetic subgroup. J. Clin. Microbiol. 44:3422-425.
13. Mehta, A. S., et al. 2006. Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium. Chem. Eur. J. 12:9136-9149.
14. Oberli, M. A., et al. 2010. Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide. J. Am. Chem. Soc. 132:10239-10241.
15. Perreten, V., et al. 2005. Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria. J. Clin. Microbiol. 43:2291-2302.
16. Pilo, P., V. Perreten., and J. Frey. 2008. Molecular epidemiology of Bacillus anthracis: getting the correct origin. Appl. Environ. Microbiol. 74:2928-2931.
17. Ryu, C., et al. 2005. Molecular characterization of Korean Bacillus anthracis isolates by amplified fragment length polymorphism analysis and multilocus variable-number tandem epeat analysis. Appl. Environ. Microbiol. 71:4664- 4671.
18. Saile, E., et al. 2011. Antibody responses to a spore carbohydrate antigen as a marker of non-fatal inhalation anthrax in rhesus macaques. Clin. Vaccine Immunol. doi:10.1128/CVI.00475-10.
19. Saksena, R., R. Adamo, and P. Kováč. 2005. Studies toward a conjugate vaccine for anthrax. Synthesis and characterization of anthrose [4,6-dideoxy-4-(3-hydroxy-3-methylbutanamido)-2-O-methyl-D-glucopyranose] and its methyl glycosides. Carbohydr. Res. 340:1591-1600.
20. Saksena, R., R. Adamo, and P. Kováč. 2006. Synthesis of the tetrasaccharide side chain of the major glycoprotein of the Bacillus anthracis exosporium. Bioorg. Med. Chem. ett. 16:615-617.
21. Saksena, R., R. Adamo, and P. Kováč. 2007. Immunogens related to the synthetic tetrasaccharide side chain of Bacillus anthracis exosporium. Bioorg. Med. Chem. Lett. 5:4283-4310.
22. Schelling, E., K. Wyss, M. Béchir, D. D. Moto, and J. Zinsstag. 2005. Synergy between public health and veterinary services to deliver human and animal health interventions in ural low income settings. BMJ 331:1264-1267.
23. Sterne, M. 1939. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. An. Ind. 13:307-312.
24. Swiecki, M. K., M. W. Lisanby, F. Shu, C. L. Turnbough, Jr., and J. F. Kearney. 2006. Monoclonal antibodies for Bacillus anthracis spore detection and functional analyses of pore germination and outgrowth. J. Immunol. 176:6076-6084.
25. Sylvestre, P., E. Couture-Tosi, and M. Mock. 2003. Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium filament ength. J. Bacteriol. 185:1555-1563.
26. Tamborrini, M., M. Holzer, P. H. Seeberger, N. Schürch, and G. Pluschke. 2010. Anthrax spore detection by a Luminex assay based on monoclonal antibodies recognizing anthrose-containing oligosaccharides. Clin. Vaccine Immunol. 17:1446-1451.
27. Tamborrini, M., et al. 2009. Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains. J. Appl. Microbiol. :1618-1628.
28. Tamborrini, M., D. B. Werz, J. Frey, G. Pluschke, and P. H. Seeberger. 2006. Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem. Int. 45:6581-582.
29. Van Ert, M. N., et al. 2007. Global genetic population structure of Bacillus anthracis. PLoS One 2:e461.
30. Welkos, S. L., and A. M. Friedlander. 1988. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathog. 2:127-39.
31. Werz, D. B., and P. H. Seeberger. 2005. Total synthesis of antigen Bacillus anthracis tetrasaccharide-creation of an anthrax vaccine candidate. Angew Chem. Int. 44:6315-6318.
32. World Health Organization. 1998. Guidelines for the surveillance and control of anthrax in humans and animals, 3rd ed. World Health Organization, Geneva, Switzerland.
33. World Organisation for Animal Health. 2009. Manual of diagnostic tests and vaccines for terrestrial animals. World Organisation for Animal Health, Paris, France.